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Abstract
According to the World Allergy Organization (WAO), approximately 20% of the 
global population suffers from allergies. As per ongoing investigations, their per-
vasiveness is expanding comprehensively. Allergic diseases are significant because 
of the high prevalence and constant increase in their costs and adverse effects on 
human life. Probiotics are proposed as an intervention for the prevention and treat-
ment of allergic diseases. Various mechanisms are considered for the anti-allergic 
effects of probiotic properties, like detecting related molecular patterns, including 
DNA motifs or lipopolysaccharides (LPS) of the bacteria, through interaction 
with host immune systems by Toll-like receptors. In this chapter, the microbiome, 
allergy, and the role of immunomodulatory probiotics against allergy are discussed.
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1. Introduction
In industrialized countries, more than 20% of the population has symptoms 
of allergies. The commonness of childhood asthma increased by 50% in the USA 
from 1980 to 2000. The allergy mechanism is an immune response to the allergen, 
which is often mediated by the immunoglobulin E (IgE) antibody [1]. Allergies can 
be a serious risk for individuals. Allergens or pollens represent a small fraction of 
the proteins that humans are regularly exposed to. The importance of the topic in 
the uncertainty is the cause of the B and T cells’ responses to these proteins [2, 3]. 
Notably, some proteins that are structurally similar pollens may lead to immune 
response, known as cross-reactivity [4].
The human body microbiome has a diverse composition of bacteria, archaea, 
fungi, protozoa, and viruses, which are inhabited mainly in the different epidermal 
surfaces of the body—the skin and mucosal surface. Some of the species of these 
microbiotas are identified based on cultural techniques, but due to limitations of 
these techniques [5], it is suggested that the number of human microbiota exceeds 
1000 species or 10 times the number of cells in the entire body with 30 times larger 
total genome than the human genome.
A majority of these microbiotas are in the gastrointestinal tract, the major source 
of microbial exposure, and live in symbiosis with their host cells [6, 7]. Given up genes 
necessary for the survival of the commensal microbiota in other microenvironments 
and retained genes beneficial for the host with no or little benefit to themselves [8] are 
the evidences of the symbiotic coevolution of the microbiota and human [9].
The interplay of the immune system with gut microbiota starts from the day of 
birth and even before that. Early exposure during plasticity and prenatal period 
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seems to be beneficial to prevent the T helper cell type-2 (Th2)-mediated allergic 
disease [10]. Th2 phenotype is the dominant one in newborns [11] to prevent 
rejection in utero. Skewing to Th2 in the immune system leads to the stimulated 
secretion of IgE by B cells and hence to allergies as seen in germ-free mice with the 
same condition that results in greater IgE responses to food antigens and failure in 
producing the proper amount of regulatory T cell (Treg) responses [12–14]. On the 
other hand, upsurge in the amount of T helper cell type-1 (Th1) also mediates the 
autoimmune disease [12, 15–19].
Restoring Th1/Th2 is the significant role of the microbiota [20]. The associa-
tion of microbiota and the immune system is mutual. This engagement results in 
different signaling pathways through the immune system’s molecules that increase 
immune responses [21]. These regulations are crucial for maintaining the homeo-
stasis of the host and for the prevention of different diseases by inducing secretion 
of IgA and regulatory T cell (Treg) and stimulation of tolerance in face of common 
antigens [22]. So the formation, maintenance, and heterogeneity of microbiota are 
necessary during early life owing to their regulatory and tolerance properties in the 
immune system [23, 24], as it was confirmed that the lack of microflora during a 
short time in early life results in defection in immune regulation [15]. The mecha-
nisms of oral tolerance which are necessary to suppress excessive immune reactions 
to antigens are mediated by Foxp3þ Treg [25] and IgA, which is known as the most 
abundant immunoglobulin and is vital in establishing the composition of micro-
biota [26] and strengthening the mucosal barrier function [27].
Although, it is observed that abnormal IgA responses lead to allergy devel-
opment [28]. So the obligation of equilibrium of the allergy mediators is more 
sensible now.
Lack of genetic elements such as Toll-like receptors that cause enterocyte 
proliferation like TLR4 and CD14, which enhance the detection of bacterial LPS by 
TLR4, and TLR9, which identify the genetic molecules of the microorganisms, also 
increase susceptibility to allergies [29, 30].
As the priority of the microbiome is proven, some factors are mentioned as 
follows, to support their presence and diversity in the body. Mode of birth; surgi-
cal or natural delivery, the process of contacting microflora in the first moment of 
the presence. Breast or formula feeding; the extension of contact with microflora. 
Nutritional patterns; the habit of food, based on people’s patterns to eat fatty and 
fast foods or healthy ones like prebiotics which are considered beneficial for even the 
microbiota of the host. Antibiotics; the matter of using antibiotics at an early age or 
the trouble of overuse of them in all ages which impair normal flora. Locality; living 
in urban areas with all of the stresses, less interaction with nature in contrast with 
living in rural areas results in losing ancient commensal microbiota. Environmental 
factors; contacting people or animals. Hygiene; the obsession behaviors or normal 
ones. Lifestyle; the matter of activity or sedentariness in someone’s lifestyle.
Natural delivery and breastfeeding are the first two initial and essential expo-
sures when the immune system is not still mature and needs antigens to active oral 
tolerance [18, 25, 31]. Contravention of these simple factors grounds reformed 
patterns of early settlement which may result in the incidence of allergy [32]. Food 
sensitization especially milk allergy and atopic eczema are examples of reduced gut 
microbial diversity [33–37].
2. The function of the intestinal microbiota
The microbiome is considered as an active organ because of manufacturing 
intrinsic signals for shifting postnatal development, inspiration of tolerance 
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mechanisms and immunogenicity reduction, and resistance against invasive 
pathogens [38–42].
Consuming substrates of the microbiota containing fibers and mucins provides 
additional energy for the host as fatty acids [43]. Amines, sulfides, and ammonia 
are the products of them, which are detrimental metabolites for the human.
The protective barrier function against the invasive microbes by their coloniza-
tion in the intestine is another potential of the microbiota. Different mechanisms 
for the resistance colonization of the microbiota are considered, such as competition 
for nutrients and connection to the binding sites and secretion of the antimicrobial 
substances [44].
Stimulation of the innate signaling pathways through the straight cell-to-cell 
communications or secretion of short-chain fatty acids (SCFA) are the other 
regulatory actions of the microbiota. SCFAs produced by the microbiota can direct 
intestinal Treg cells and inhibit pro-inflammatory responses [45–48].
3. The intestinal microbiota of allergic ones
The role of maternal microbiota in the process of preventing allergy has been 
proven. Infants from allergic parents are at least twice more likely to the risk of 
developing allergic diseases than nonallergic parents. Microbiota diversity exists 
between allergic and nonallergic persons. Reduction in the fecal diversity of the 
bacteroidetes in pregnancy is connected with the prevalence of atopic eczema 
in their young children [49]. The microbiota of healthy infants with nonallergic 
parents frequently consists of healthy lactobacilli, representing the role of maternal 
microbiota in preventing allergic disorders. A decrease in the number of lactobacilli 
and bifidobacteria and an increase in the colonization of Staphylococcus aureus and 
Clostridium difficile are associated with the development of allergic disorders later 
in life, which shows the abnormality even before the onset of the allergy [50, 51]. 
Apart from quantitative alterations, qualitative alterations are important in the 
microbiota. For example, the microbiota of infants suffering from atopic dermatitis 
(AD) consists of mostly B. adolescentis which is mainly forming adult microbiota, 
whereas B. bifidum is the fundamental former of the healthy breastfeeding infants 
[52, 53]. Bifidobacteria of atopic dermatitis infants encourage the secretion of pro-
inflammatory cytokines, whereas the bifidobacterium of healthy ones encourages 
the secretion of anti-inflammatory cytokines [54]. Besides, these bifidobacteria 
have different adhesion behaviors to Caco-2 tissue culture cells [55] and intestinal 
mucus [56], which seems to be the reason for the reduction in stimulating the 
immune system. And at last, the metabolic activity of the microbiota composition 
is different too. Higher levels of butyrate, isovalerate, and caproate in the fecal 
matter of children with high risk for developing allergy in comparison with normal 
children are the confirmation of this claim [57].
4. Stabilizing intestinal bacterial flora
The intestine, the largest immune organ of the body, which is the source of the 
most antibody-producing cells [58] is the target of triggering maturation of the 
immune system or the restoration of the impaired commensal bacteria. Stimulation 
of the immune system is one of the most impressive functions of the resident 
microbiota of the intestine. Probiotic bacteria are considered as a safe solution 
for modulation of diminished commensal composition and also as influencer of 
the immune system in preventing allergic disorders [59]. Lactic acid bacteria and 
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bifidobacteria are good candidates as probiotics with an appropriate life span, no 
toxic or pathogenic properties, and no inflammatory induction. The selection of the 
bacteria as probiotics is mainly based on no harmful side effects during the history 
of their use for a long time. Consumption of these probiotics aid in balancing the 
ratio of the intestinal flora, avoiding the inhabiting of the pathogens by preventing 
the binding of them to the host cells, and suppressing the inflammation, which all 
are as the result of immune system regulation [60]. The effects of probiotics vary 
with the dose, strain, and duration of consumption and timing.
But the problem of the probiotics is their longevity and residence in the body of 
the host, as it was seen that they only remain during the administration period and 
not after that, showing the transient colonization of the probiotics [61–65].
Long-term effects of probiotics in different periods of everyone’s life need to be 
more investigated in complementary studies.
As it was mentioned, immune tolerance is one of the necessary immune reac-
tions to stop excessive inflammatory reactions. Preservation of this tolerance 
involves the integrity of the epithelial barrier that is heightened by commensal 
anaerobes, such as Clostridium spp. [15, 16, 66, 67], Bacteroides fragilis [68], and 
Clostridium spp. [66, 67], which are potent inducers, persuading Foxp3þ Treg dif-
ferentiation to maintain mucosal tolerance and intestine integrity. Clostridia class 
also has adaptation properties in the intestinal cells to the routine exposure of an 
extended range of the antigens. This adaptation is acquired by the effect of IL-22 
secreted by innate lymphoid cells which control enterocyte proliferation, activating 
the secretion of the mucus and antimicrobial production [16, 69].
5. Probiotics’ mechanisms of action in allergic disorders
Immune homeostasis develops in the gut as a relationship between the intestinal 
microbiota, the luminal antigens, and the epithelial barrier is established. Microbial 
intestinal colonization starts after conception. This happens when the newborn’s 
sterile gut is slowly colonized by environmental bacteria and by interaction with the 
mother’s intestinal flora and surroundings and probably by genetic factors [70–72]. 
Exposure to microbial flora early in life causes a transition in the T helper cell type-1 
(Th1)/Th2 cytokine balance, promoting a Th1 cell response [73].
An infant’s immune system at birth is not completely formed and appears to be 
geared toward a Th2 phenotype to prevent in utero rejection [74]. Nevertheless, the 
Th2 phenotype results in a stimulated production of IgE by B cells and therefore 
raises the risk of allergic reactions by mast cells activation [75, 76]. Early in life 
microbial stimulation will reverse the Th2 bias and promote the expansion of the 
Th1 phenotype and promote Th3 cell activity [76]. In this way, their combined 
activity will lead to B-cells releasing IgA. IgA contributes to the elimination of 
allergens and hence would reduce the immune system’s response to antigens. Th1 
phenotype-produced cytokines will also reduce inflammation and promote toler-
ance toward specific antigens [77].
The hygiene concept states that inadequate or aberrant exposure to environmental 
microbes is one of the triggers of allergy production and related diseases [78]. As men-
tioned before, allergic diseases are associated with a change in the Th1/Th2 cytokine 
balance leading to Th2 cytokine activation and interleukin-4 (IL-4), IL-5, and IL-13 
activation as well as IgE production [79, 80]. Probiotics significantly alter the gut 
microenvironment by encouraging a shift in local microflora and cytokine secretion 
[81] and can potentially modulate enterocyte Toll-like receptors and proteoglycan 
recognition proteins, resulting in dendritic cell (DC) activation and a Th1 response. 
The resulting stimulation of Th1 cytokines can suppress reactions to Th2 [82].
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6. Probiotics in atopic dermatitis
Atopic dermatitis (AD) is a widespread chronic inflammatory skin condition 
with a prevalence of around 20% in children and 2–5% in adults worldwide [83]. 
In recent years, the function of the intestinal microbiota in the aetiopathogenesis 
of AD has become increasingly important. Atopic dermatitis probiotic therapy 
is widely studied, with contradictory outcomes [84]. Probiotics containing 
Lactobacillus spp. for the treatment of infantile atopic dermatitis showed beneficial 
effects in children. Caution should however be raised when treating children under 
the age of 1 years of age [85]. In addition, mild subjects are exceptions to that 
beneficial effect. More studies could be informative in investigating the efficacy of 
Bifidobacterium strains. Further larger studies in the treatment of pediatric AD are 
also required to examine the health, dose-response profile, and long-term impact of 
probiotics [86].
7. Probiotics in asthma
Asthma, a chronic complex airway disease, is characterized by reversible airflow 
obstruction, bronchial hyper responsiveness, and underlying inflammation [87]. In 
recent decades, the prevalence of asthma has risen. One possible mechanism behind 
this high prevalence is the microbial hypothesis, which suggests that less microbial 
exposure upregulates T helper cell type-2 (Th2) cytokine development, leading to a 
rise in allergic diseases [75]. A meta-analysis found that while perinatal and early-life 
probiotic administration reduces children’s risk of atopic sensitization and total rates 
of immunoglobulin E (IgE), it may not reduce their risk of asthma [88]. However, 
in addition to routine treatment, several studies have documented the advantage 
of using probiotics for treating children with asthma. A randomized, placebo-
controlled trial for 7-week treatment with Enterococcus faecalis showed reduced peak 
flow variability in children with asthma [89]. Lee et al. have reported substantial 
improvements in the pulmonary function of children with asthma following a 
regimen of supplementation of vegetables, fish oil, and fruit along with probiotic 
administration. Studies, however, have shown that Lactobacillus is safe for children 
with asthma [90, 91].
8. Probiotics in allergic rhinitis
On these bases, probiotic bacteria are capable of altering immune responses 
through a range of mechanisms that could minimize allergic reactions to airborne 
allergens without the side effects of any current drugs, and these possible mecha-
nisms, as shown in Figure 1, include regulatory T cells that dampen immune 
responses and suppress the production of IgE antibodies [92, 93]. There are contra-
dictory studies about the effectiveness of probiotics in treating allergic rhinitis [94]. 
It is reported that L. casei decreased the number of episodes of rhinitis in 64 pre-
schoolers with allergic rhinitis [95]. Nonetheless, another study found that patients 
treated with Lactobacillus GG during the birch pollen season who were allergic 
to birch pollen and apple food found no improvement in symptom score and no 
reduced sensitivity to birch pollen and apple following probiotic supplementation 
[96]. Probiotic consumption increased life performance in allergic rhinitis patients. 
Blood or immunological parameters did not alter significantly in the probiotic 
community. This indicates probiotics may be useful in allergic rhinitis, but the data 
present are not sufficient to make any guidelines for treatment [97, 98].
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9. Probiotics in food allergy
Food allergy (FA) is one of the pediatric age’s most common allergic disorders 
and has been considered a global health issue, particularly in the developed 
world.
Naturally, many subjects with FA outgrow this over time. Cow’s milk allergy 
(CMA), hen’s egg allergy, and wheat allergy resolve by 5–10 years in 50% of chil-
dren. Many FAs (including peanuts, tree nuts, and fish) have low-resolution levels 
and are seen as persistent [99]. Furthermore, certain types of FA may be correlated 
with the subsequent development of other allergic symptoms such as oculorhinitis, 
atopic dermatitis, asthma, and urticaria (the so-called “Atopic March”) [100] as 
well as other diseases such as functional gastrointestinal disorders (FGIDs), inflam-
matory intestinal diseases (IBD) [101], and psychiatric disorders such as attentive 
autistic spectrum disorders (ASD).
The gut microbiome-immune system axis that influences the frequency of FA 
may be modulated by several genetic, environmental, and dietary factors [102]. 
For example, increased family size, pet and/or rural exposure, balanced diet (full 
of fibers, fermented foods, antioxidants, omega-3), breastfeeding, and probiotic 
use are correlated with FA safety. Conversely, C-section, prenatal, and early-life 
exposure to antibiotics/gastric acid inhibitors/antiseptic agents, unhealthy diet (low 
fibers/high saturated fats, and junk foods) may increase the risk of developing FA. 
All these environmental factors mainly operate on a modulation of the structure 
and function of the gut microbiota, which may in effect be responsible for the 
epigenetic control of genes involved in immune tolerance.
The pathogenesis of these incidents also is largely unknown, but increasing 
evidence suggests the hypothesis that disturbance of intestinal microbiome, leading 
to alterations in the immune system and gut-brain axis, may affect the occurrence 
of FA and FA-related conditions later in life [103] (Figure 2).
Figure 1. 
Probiotic mechanism against the allergen include increasing regulatory T cells that damp down immune 
responses and suppress the production of IgE.
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Mediterranean diet (MD) is described as a healthy, balanced diet. It is associ-
ated with a high intake of assorted cereals, legumes, fruit, vegetables, olive oil, and 
nuts; moderate consumption of red wine, poultry, and fish; and a lower intake of 
red meat and sweets. MD has been shown to have a protective role against allergic 
illnesses in children during pregnancy and early life [104].
Elevated adherence to MD was associated with increased levels of Prevotella 
and other Firmicutes and production of short-chain fatty acids (SCFAs) [102]. One 
of the strongest links between diet, gut microbiome, and allergic diseases is the 
immunomodulatory mechanisms elicited by SCFAs [105]. Common SCFAs contain 
acetate, butyrate, propionate, and valerate. SCFA-producing bacteria include 
Faecalibacterium prausnitzii and Eubacterium rectale. Roseburia is an important 
butyrate producer [106]. SCFAs are a major source of energy for colonocytes and 
epigenetically influence many nonimmune functions (tightened junction proteins, 
and mucus production) and immune functions (macrophages, neutrophils, den-
dritic cells (DCs), and T and B cells) [107, 108]. Enterocyte interaction of SCFAs 
is mediated by G-protein-coupled receptors, namely GPCRs, GPR41, GPR43, 
GPR109A, and Olfr78 [109, 110]. The hopeful target of novel therapeutic and pre-
ventive approaches against FA may be the gut microbiome. The results of the studies 
are promising, but more research is needed for the better definition of the potential 
for diet-gut microbiome—immune system axis modulation to counter FA. We are 
entering a new age in which the production and function of the immune system can 
be controlled by dietary intervention, and the clinical effect can be assessed by gut 
microbes and their metabolites. Given the current gaps in research methods and 
data analysis and interpretation, more scientific evidence is required which can be 
converted into clinical evidence praxis [103].
10. Conclusion
The results of many studies have demonstrated that there is a strong relationship 
between modifications within the microbiome and many diseases. Much evidence 
proves that healthy microbiota affects and improves the immune system. It seems 
that probiotics can have an important role in the prevention of many diseases such 
as allergy. Microbiota diversity exists between allergic and nonallergic persons. 
Different mechanisms are considered for the anti-allergic impact of probiotics, like 
detecting related molecular patterns, including DNA motifs or LPS of the bacteria 
Figure 2. 
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